Literature DB >> 14794967

The effect of antibiotics on agents of the psittacosis-lymphogranuloma group.

F M GOGOLAK, E WEISS.   

Abstract

Entities:  

Keywords:  AUREOMYCIN; LYMPHOGRANULOMA; PSITTACOSIS

Mesh：

Substances：

Year:  1950        PMID： 14794967     DOI： 10.1093/infdis/87.3.264

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  [Progress in the chemotherapy and antibiotic therapy of trachoma. Tests of effectiveness, new products, intermittent treatment].

Authors:  G B BIETTI
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

2.  [Aureomycin in experimental psittacosis in the mouse].

Authors:  W SCHMIDT; H VON SPROCKHOFF
Journal:  Z Hyg Infektionskr       Date:  1953

3.  The therapy of experimental psittacosis and lymphogranuloma venereum (inguinale) II. The activity of quinoxaline-1:4-dioxide and substituted and related compounds, with a note on the morphological changes induced in lymphogranuloma virus by these compounds and by antibiotics.

Authors:  E W HURST; J K LANDQUIST; P MELVIN; J M PETERS; N SENIOR; J A SILK; G J STACY
Journal:  Br J Pharmacol Chemother       Date:  1953-09

4.  Terramycin in early lymphogranuloma venereum.

Authors:  K S HENLEY
Journal:  Br J Vener Dis       Date:  1953-03

5.  Ultrastructural analysis of the effects of penicillin and chlortetracycline on the development of a genital tract Chlamydia.

Authors:  M J Kramer; F B Gordon
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

6.  Studies on the psittacosislymphogranuloma group. III. The effect of aureomycin on the propagation of virus in the chick embryo.

Authors:  E G ALLEN; A J GIRARDI; M M SIGEL; M KLEIN
Journal:  J Exp Med       Date:  1953-06       Impact factor: 14.307

7.  Localized Peptidoglycan Biosynthesis in Chlamydia trachomatis Conforms to the Polarized Division and Cell Size Reduction Developmental Models.

Authors:  George W Liechti
Journal:  Front Microbiol       Date:  2021-12-09       Impact factor: 5.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.